维生素K_2与骨质疏松症的研究进展  

Research progress of vitamin K_2 and osteoporosis

作　　者：王强[1] 王声雨[1] 顾群[1] 陶树清[1] 陶天遵[1] 荣杰生[1] 

机构地区：[1]哈尔滨医科大学附属第二临床医学院骨二科,150086

出　　处：《中国骨与关节杂志》2013年第11期655-658,共4页Chinese Journal of Bone and Joint

摘　　要：骨质疏松症是一种骨量降低，骨组织微结构破坏，以骨脆性增加，骨强度下降，骨折风险增加为特征的全身骨骼系统疾病。近年来，随着老龄化人数的增加，骨质疏松症已经严重威胁了中老年人身体健康，成为人类社会共同关注的重要健康问题。据一项全国性流行病学调查显示，50岁以上男性骨质疏松症患病率为14．4％，女性升高到20．7％，60岁以上人群的患病率进一步升高。With the acceleration of aging process in human society, the number of osteoporosis patients is increasing day by day. By now osteoporosis has become a serious threat to the health of middle and old aged people. Vitamin K, also known as blood coagulation vitamin, plays a role in many aspects of the bone metabolism, including bone formation, bone resorption, increasing bone strength, improving bone quality, and reducing the risk of osteoporotic fractures. It is effective in the treatment of osteoporosis caused by a variety of factors. Because of few side effects, low toxicity and beneficial effects, more and more attention has been paid to vitamin K2. The recent research progress of vitamin K2 and osteoporosis is reviewed in this article.

关 键 词：男性骨质疏松症 维生素K2 骨骼系统疾病 流行病学调查 骨折风险 身体健康 中老年人 健康问题 

分 类 号：R580[医药卫生—内分泌]